Recent Story Posts
Innovation
Four Questions with Mark Chao and Mauro Avanzi: Bringing Therapeutic Advances for Blood Cancers from Bench to Bedside
Innovation
Four Questions with Daejin Abidoye: Following Science to Find Ways to Help People Living with Cancer
Community
World AIDS Day Marked Amid COVID-19 Pandemic
Recent Press Releases
-
November 24, 2020
Gilead Sciences to Present at the 3rd Annual Evercore ISI HealthCONx Conference on Wednesday, December 2, 2020 -
November 18, 2020
Gilead Announces Investigational Long-Acting HIV-1 Capsid Inhibitor, Lenacapavir, Achieves Primary Endpoint in Phase 2/3 Study in Heavily Treatment-Experienced People Living With HIV
For more information, contact us.
Phone:
1-800-GILEAD-5 (1-800-445-3235)
1-800-GILEAD-5 (1-800-445-3235)